Prostate cancer decisions — 2026

The Board denied the Veteran's claim for SMC in excess of SMC(n) based on his service-connected conditions and additional disabilities, as well as his need for aid and attendance. The appeal was dismissed.

The Veteran's appeal for an increased evaluation of his depressive disorder and entitlement to a total disability rating based on individual unemployability (TDIU) is denied as the November 2024 rating decision was not adjudicating previously pursued claims.

The Board has determined that the Veteran's prostate cancer did not begin during service or is not related to any in-service injury or disease, including exposure to herbicides and/or asbestos. The claim for service connection for prostate cancer is denied.

The Veteran's claims for increased ratings and service connection have been granted, with some issues being granted through all appellate periods. The RO has also confirmed the evaluations and effective dates from previous decisions.

The Board has determined that prostate cancer is service-connected due to exposure at Camp Lejeune, and the Veteran's age was not a factor in his diagnosis.

The Board has decided to remand the cases of reducing the rating for prostate cancer and determining entitlement to TDIU due to issues with obtaining necessary medical records.

The Board has restored the Veteran's 100% rating for prostate cancer and granted restoration of SMC at the housebound rate due to his service-connected disabilities, effective July 1, 2025.

The Veteran's claim for service connection for prostate cancer is being remanded due to the need for a new medical opinion regarding his exposure to toxic substances in service.

The Board has granted service connection for prostate cancer, finding it at least likely as not that the Veteran's current condition is related to his in-service exposure to atomic projectiles.

The Board has remanded the claims for prostate cancer and urinary incontinence, as well as unstable ambulation secondary to vertigo. The Veteran's service connection requests are based on new evidence submitted after the initial decision.

The Veteran's claim for service connection for hearing loss in the right ear has been denied. The Board found that there is no current diagnosis of right ear hearing loss and thus, cannot establish a link to service. For prostate cancer, the Veteran's claim is remanded as VA did not provide an opinion regarding whether his condition may be related to service due to toxic exposure.

The Board has decided to remand the claims for service connection for prostate cancer, Alzheimer's disease, pseudophakia, spine tumor, and a heart condition due to potential errors in obtaining all relevant medical records and considering the Veteran's exposure to toxic environmental risk activities (TERA) during his military service.

Your appeals for prostate cancer and right hip arthritis have been dismissed due to the Veteran's passing. The Board cannot issue a decision on these claims as they are no longer pending.

The Veteran's prostate cancer is found to be related to his service at Camp Lejeune, where he was exposed to toxic substances. The Board has granted service connection for this condition.

The Board has remanded the claims of entitlement to dependency and indemnity compensation for service connection for metastatic prostate cancer, as well as the claim for service connection for cause of death due to a duty to assist error. The remand is necessary because the VA examiner did not address whether the Veteran's TCE exposure during service was related to his prostate cancer.

The Veteran's prostate cancer is remanded due to pre-decisional duty to assist errors, including the need for a new TERA Memorandum and updated Individual Longitudinal Exposure Record (ILER).

The Veteran's prostate cancer is remanded for additional development, including a VA examination to determine if it is related to his in-service MOS as a Cable Splicing Maintenance Specialist and exposure to toxic materials.

The Board denied the appellant's request to restore a higher level of special monthly compensation (SMC) based on CUE in the April 2024 rating decision, as the prior award was based on a temporary 100% schedular rating for prostate cancer.

The Veteran's neurogenic bladder with voiding dysfunction is granted a 10 percent rating, effective January 24, 2025. The claim for service connection for adenocarcinoma of the colon is remanded.

The Veteran's service-connected disabilities, including prostate cancer, CAD, and bilateral lower extremity nerve damage, have rendered him unable to secure or follow a substantially gainful occupation. The Board has granted the TDIU.